Business · 22/05/2024Updated: 10/17/2026 · 1 min read

FDA to Host Public Workshop on Immunosuppressive Effects of In Utero Drug Exposure

The FDA is hosting a public workshop to discuss the potential effects of in utero exposure to immunosuppressive drugs and biologics on fetal development and newborns, with the goal of improving data collection and understanding the clinical implications.